Bionik Laboratories Corp. – ‘10-K’ for 12/31/14 – ‘EXCEL’

On:  Wednesday, 4/15/15, at 4:40pm ET   ·   For:  12/31/14   ·   Accession #:  1014897-15-132   ·   File #:  0-54717

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    273K 
 2: EX-14.1     Code of Ethics -- exhibit141                        HTML     60K 
 3: EX-21       Exhibit 21.1                                        HTML     15K 
 4: EX-31       Certification -- §302 - SOA'02 -- exhibit31         HTML     24K 
 5: EX-32       Certification -- §906 - SOA'02 -- exhibit32         HTML     21K 
31: R1          Document and Entity Information                     HTML     47K 
24: R2          Bionik Laboratories Corp. (f/k/a Drywave            HTML     63K 
                Technologies, Inc.) Consolidated Balance Sheets                  
29: R3          Bionik Laboratories Corp. (f/k/a Drywave            HTML     42K 
                Technologies, Inc.) - Consolidated Balance Sheets                
                (Parantheticals)(Usd $)                                          
33: R4          Bionik Laboratories Corp. (f/k/a Drywave            HTML     50K 
                Technologies, Inc.) - Consolidated Statements of                 
                Operations                                                       
44: R5          Bionik Laboratories Corp. (f/k/a Drywave            HTML     37K 
                Technologies, Inc.) - Consolidated Statement of                  
                Changes in Stockholders' Equity (Deficit) For the                
                Years Ended December 31, 2014 and 2013                           
25: R6          Bionik Laboratories Corp. (f/k/a Drywave            HTML     54K 
                Technologies, Inc.) - Consolidated Statements of                 
                Cash Flows                                                       
28: R7          Note 1 Nature of Operations                         HTML     23K 
21: R8          Note 2 Summary of Significant Accounting Policies   HTML     33K 
15: R9          Note 3 Going Concern                                HTML     22K 
45: R10         Note 4 Related Party Transactions                   HTML     25K 
35: R11         Note 5 Stockholders' Deficit                        HTML     29K 
34: R12         Note 6 Income Taxes                                 HTML     22K 
39: R13         Note 7 Commitments and Contingencies                HTML     22K 
40: R14         Note 8 Subsequent Events                            HTML     36K 
38: R15         Note 2 Summary of Significant Accounting Policies:  HTML     20K 
                Basis of Presentation (Policies)                                 
41: R16         Note 2 Summary of Significant Accounting Policies:  HTML     23K 
                Principles of Consolidation (Policies)                           
30: R17         Note 2 Summary of Significant Accounting Policies:  HTML     24K 
                Development Stage Entity (Policies)                              
32: R18         Note 2 Summary of Significant Accounting Policies:  HTML     20K 
                Use of Estimates (Policies)                                      
37: R19         Note 2 Summary of Significant Accounting Policies:  HTML     22K 
                Cash and Cash Equivalents (Policies)                             
48: R20         Note 2 Summary of Significant Accounting Policies:  HTML     21K 
                Property and Equipment (Policies)                                
42: R21         Note 2 Summary of Significant Accounting Policies:  HTML     19K 
                Due To Related Party (Policies)                                  
26: R22         Note 2 Summary of Significant Accounting Policies:  HTML     20K 
                Financial Instruments (Policies)                                 
36: R23         Note 2 Summary of Significant Accounting Policies:  HTML     22K 
                Revenue Recognition (Policies)                                   
27: R24         Note 2 Summary of Significant Accounting Policies:  HTML     20K 
                Advertising Expenses (Policies)                                  
14: R25         Note 2 Summary of Significant Accounting Policies:  HTML     24K 
                Income Taxes (Policies)                                          
43: R26         Note 2 Summary of Significant Accounting Policies:  HTML     21K 
                Stock Based Compensation (Policies)                              
46: R27         Note 2 Summary of Significant Accounting Policies:  HTML     23K 
                Earnings (loss) Per Share (Policies)                             
18: R28         Note 2 Summary of Significant Accounting Policies:  HTML     19K 
                Reclassification (Policies)                                      
17: R29         Note 2 Summary of Significant Accounting Policies:  HTML     19K 
                Recent Accounting Pronouncements (Policies)                      
19: R30         Note 3 Going Concern (Details)                      HTML     30K 
20: R31         Note 4 Related Party Transactions (Details)         HTML     24K 
22: R32         Note 6 Income Taxes (Details)                       HTML     27K 
13: R33         Note 8 Subsequent Events (Details)                  HTML     43K 
47: XML         IDEA XML File -- Filing Summary                      XML     69K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX     51K 
16: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    113K 
 6: EX-101.INS  XBRL Instance -- dwtp-20141231                       XML    149K 
 8: EX-101.CAL  XBRL Calculations -- dwtp-20141231_cal               XML     35K 
 9: EX-101.DEF  XBRL Definitions -- dwtp-20141231_def                XML     60K 
10: EX-101.LAB  XBRL Labels -- dwtp-20141231_lab                     XML    240K 
11: EX-101.PRE  XBRL Presentations -- dwtp-20141231_pre              XML    195K 
 7: EX-101.SCH  XBRL Schema -- dwtp-20141231                         XSD     76K 
23: ZIP         XBRL Zipped Folder -- 0001014897-15-000132-xbrl      Zip     32K 

‘EXCEL’   —   IDEA Workbook of Financial Reports (.xls)

This is an IDEA Workbook.

	Download this Microsoft® Excel® .xls workbook
Web Archive:	This document is a Single File Web Page, also known as         a Web Archive file.  To view this Workbook file format,         your browser or editor must support Web Archive files.

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/21/23  Bionik Laboratories Corp.         10-K        3/31/23   78:8.6M                                   Toppan Merrill/FA2
 6/09/22  Bionik Laboratories Corp.         10-K        3/31/22   68:7.9M                                   Toppan Merrill/FA2
 6/24/21  Bionik Laboratories Corp.         10-K        3/31/21   71:6.3M                                   Toppan Merrill/FA